Ann: Replacement Prospectus, page-5

First 5 Last

Share
Profile

Follow
xindongzuitaohua

4,793 Posts.

90

03/02/17

12:40

Post #: 22349090
Share

Originally posted by shikobebaby ↑

FYI (from other thread):

I forgot to mention the seed investors (which most IPOs have) that got in super cheap. They converted their convertible notes at 1¢ and 8¢. The guys sitting on 1,900% profit should definitely be churned out by now (3.5M shares). However, the ones at 150-200% (6.5M shares) are still waiting on the sidelines for suckers to push the price higher before they dump with no remorse.

Also, we have BPL shareholders that got (35M) in specie distribution of COB shares. They were created via a 10,000 to 35,000,000 split of $10,000 worth of shares. If you do the math, that's 0.02857¢/share LOL. If they sell at 20¢, that's a 69,904% profit! Pretty good deal. LOTS more churning to go, so buyers be smart, please.

Note: I didn't take into account the 22,7M shares that are escrowed for at least 12-24 months. That's, however, only 50.4% of the shares mentioned above. 12M trades yesterday and around 3M trades today, we still have 8-10M shares to churn. Also, you shouldn't expect the churn to be clean, so it's better to be patient until the volume is right before buying.

GLTAH

Expand

dont you know those 22m Escowded shares should include SEEDS share????

go check all other IPO and check what kind of shares are escowded before misleading here....

COB Price at posting: 20.0¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

There are more pages in this discussion • 9 more messages in this thread...

First 5 Last

Add COB (ASX) to my watchlist

(20min delay)
Last 8.6¢		Change -0.003(3.37%)		Mkt cap ! $36.33M

Open	High	Low	Value	Volume
8.9¢	9.3¢	8.5¢	$88.42K	1.001M

Buyers (Bids)

No.	Vol.	Price($)
4	65611	8.5¢

Sellers (Offers)

Price($)	Vol.	No.
8.6¢	38004	1

View Market Depth

No.	Vol.	Price($)
4	65611	0.085
3	37656	0.083
1	10000	0.081
3	211500	0.080
2	26435	0.078

Price($)	Vol.	No.
0.086	38004	1
0.088	23677	1
0.092	40000	1
0.093	187442	3
0.094	60000	1

Last trade - 16.10pm 07/10/2024 (20 minute delay)

COB (ASX) Chart

Ann: Replacement Prospectus, page-5

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Replacement Prospectus, page-5

Top Stories

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News